BriaCell Therapeutics's total assets for Q3 2025 were $17.00M, an increase of 81.57% from the previous quarter. TSE:BCT total liabilities were $5.06M for the fiscal quarter, a -17.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.